Peregrine Pharmaceuticals shares owned by Kerrisdale Advisers
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Kerrisdale Advisers
from 13F filings
Historical chart of Kerrisdale Advisers investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Kerrisdale Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Peregrine Pharmaceuticals by Kerrisdale Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $463k | 49k | 9.44 |